Renin-Angiotensin-Aldosterone System/Endocrine Hypertension

FP40-1

Prevalence of benign and malignant secondary neoplasms in patients with primary aldosteronism
Katharina Lang, Katrin Weber, Marcus Quinkler, Anna Pallauf, Henri Wallaschofski, Anke Hannemann, Oliver Vonend, Holger Willenberg, Martin Reincke, Bruno Allolio and Stefanie Hahner

FP40-2

Clinical and histopathological manifestation of KCNJ5 mutations in primary aldosteronism
Kazutaka Nanba, Kuniko Sawai, Mika Tsuiki, Aya Tsumagari, Kanako Nakao, Takeshi Usui, Tetsuya Tagami, Hiroshi Okuno, Tetsuro Yamamoto, Kazuto Shigematsu, Koshiro Nishimoto, Kuniaki Mukai, Akira Shimatsu and Mitsuhide Naruse

FP40-3

Prevalence of primary aldosteronism depends on the means of case detection: prospective multi-center study of National Hospital Organization in Japan (PHAS-J2)
Mitsuhide Naruse, Yasushi Miyazaki, Takeshi Tanaka, Masatoshi Shimizu, Sumire Otani, Shirou Hata, Atsushi Ogo, Kazuya Yonezawa, Kazuo Yoshida, Morio Sawamura, Rika Araki, Makito Tanabe, Mika Tsuiki, Aya Tsumagari, Kazutaka Nanba, Tomoko Suzuki, Takurou Shimbo and Study PHASJ

FP40-4

PLASMA MATRIX METALLOPROTEINASES ACTIVITY IN HYPERTENSIVE CHILDREN DUE TO 11ß-HSD2 DEFICIENCY ACTIVITY
Alejandro Martínez-Aguayo, Carmen Campino, Hernan García, Marlene Aglony, Carolina Avalos, Lilian Bolte, Rodrigo Diaz Bancalari, Carolina A Loureiro, Cristian A Carvajal, Lorena García, Sergio Lavanderos and Carlos E Fardella

FP40-5

Cross-Talk between Oxidized LDL, Angiotensin II and Oxidative Stress after AT1 Blockade and AT1a/AT1b double knockout
Henning Morawietz, Rusan A. Catar, Claudia Goettsch, Ashraf Taye, Anja Hofmann, Coy Brunssen, Gregor Muller, Susann Lehmann, Undine Schubert, Barbara Ludwig, Christian G Ziegler, Stefan Richard Bornstein, Alexander Wolfgang Krug and Thomas Walther

FP40-6

The Role of miR-320a in the Regulation of CYP17A1 and CYP11A1 Expression
Louise Diver, Stacy Wood, Scott MacKenzie, John M Connell and Eleanor Davies